These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30372535)

  • 1. Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease.
    Castro Narro GE; Gamboa Domínguez A; Consuelo Sánchez A; Salazar Martínez A; Agramonte Hevia J; Cebolla JJ; Cuellar Mendoza ME; Díaz Hernández HA
    Hepatology; 2019 Apr; 69(4):1838-1841. PubMed ID: 30372535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatology 2008].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1366-9. PubMed ID: 18553264
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined hepatocellular and cholangiocarcinoma arising in a cirrhotic liver. Report of an autopsy case.
    Sonobe H; Hayashi K; Takahashi K; Ohtsuki Y; Matsumoto K; Onishi S; Jinno K
    Acta Pathol Jpn; 1987 Dec; 37(12):1945-52. PubMed ID: 2833062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocarcinoma in a child with cholesterol ester storage disease.
    Riva S; Spada M; Sciveres M; Minervini M; Cintorino D; Maggiore G; Gridelli B
    Dig Liver Dis; 2008 Sep; 40(9):784. PubMed ID: 18339594
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary malignancy.
    Jones BA; Gores GJ
    Clin Liver Dis; 1998 May; 2(2):437-49, xi-xii. PubMed ID: 15560042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.
    Sagrini E; Iavarone M; Stefanini F; Tovoli F; Vavassori S; Maggioni M; Renzulli M; Salvatore V; Stefanescu H; Colombo M; Bolondi L; Piscaglia F
    United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for liver biopsy in liver tumors].
    Stölzel U; Tannapfel A; Wittekind C; Hamm B; Schuppan D
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1041-4. PubMed ID: 11022600
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome is also a risk factor for primary liver cancer in patients younger than 65 years of age?
    Montella M; Polesel J; Talamini R; Crispo A; Giudice A; Izzo F; La Vecchia C
    Hepatology; 2011 Dec; 54(6):2277-8. PubMed ID: 21898495
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus.
    Peng NF; Li LQ; Qin X; Guo Y; Peng T; Xiao KY; Chen XG; Yang YF; Su ZX; Chen B; Su M; Qi LN
    Ann Surg Oncol; 2011 May; 18(5):1258-66. PubMed ID: 21207172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R; Malhotra V; Kumar N; Sarin SK
    Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma.
    Fujii T; Zen Y; Nakanuma Y
    J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.
    Chin S; Kim Z
    Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.